U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07938034) titled 'A Study of SYH2053 Injection in Participants With Renal Impairment Compared to Participants With Normal Renal Function' on July 02.
Brief Summary: This study is a Phase I, single-dose, open-label trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of a single dose of SYH2053 injection in participants with moderate, and severe renal impairment compared to participants with normal renal function.
Study Start Date: July 15
Study Type: INTERVENTIONAL
Condition:
Renal Impairment
Intervention:
DRUG: SYH2053
subcutaneous injection
Recruitment Status: RECRUITING
Sponsor: CSPC Zhongnuo Pharmaceutical (...